mechanism of action. Propofol effects on stress response and free radicals become important because as an anesthetic agent, propofol can be used as an adjuvant therapeutic agent in high stress condition and free radicals. (1) Propofol or β,6-diisoproilfenol has an empiric form C 12 H 18 O with molecular weight 178.β7. Partition coeficient octanol/water of propofol is 6.761:1 at pH 6-8.5 with pKa 11. Propofol is hydrophobic so it formulated as a white oil emulsion in water contains 1% or 2% propofol, 10% bean oil, 1.2% egg phosphatide and 2.25% glycerol. Disodium edetate (EDTA) was added to block bacterial and fungi growth. (1,β) Propofol is a sedative hipnotic anesthetic agent and can eliminate consciousness rapidly. The induction can be achieved with intravenous dose 2-2.5 mg/kgBW. Anesthesia could be maintained with continue infusion of propofol 6-1β mg/kgBW/hour or with an intermitten boluses 20-50 mg. There is no accumulation effect and propofol has a rapid recovery time, lipophylic and can get across blood brain barrier. After a single bolus with 2.5 mg/kg dose, propofol plasma concentration will decline rapidly in 10 minutes to less than 1 µg/mL which is the mean propofol concentration in human when awake from anesthesia.(1,β) Propofol level in human blood can be calculated with high performance liquid chromatography (HPLC) as a gold-standard method.
Effect to Cerebral Activity
Propofol causes dose dependent CNS depression, can get across blood brain barrier and suppress electroencephalography (EEG) activity caused by neuron activity reduction than direct effect to cerebral capillary. Propofol reduces CBF, CMR and Cerebral Perfusion Pressure (CPP), resulting ICP reduction. This effect has a positive implement to patient with raised ICP as in severe preeclampsia. Propofol also has brain protection effect through CBF and CMR reduction so oxygen consumption decreases and lower the ischemia risk. Propofol more effective than other agents in decreasing abnormal ion wave that happened during cerebral ischemia. No accumulation effect and rapid recovery time, that propofol has a positive beneit after surgery so neurologic examination could be done immediately, especially in severe preeclampsia which is impaired conscious level and neurologic disturbances often found. (1,β) Effect to Cardiovascular System Propofol causes systolic and diastolic depression, myocardial contractility, cardiac output and stroke volume suppression. Propofol can cause dose and time dependent hypotension with negative inotropic effect and vascular system resistance reduction. Even this effect seems positive in severe preeclampsia with high blood pressure but excessive hypotension and myocardial contractility suppression will give a contrary effect. Vital sign monitoring is a must during propofol procedure. Nevertheless, in single dose or continue maintenance infusion dose, there is no electrocardiography (ECG) rhythm changes. Tachycardia, not bradycardia, occurred at the last hours in animal experiment after 38 hours continue anesthetized. (1,β) Drugs to increase blood pressure if hypotension occurs such as ephedrine and phenilephrine must be given
Pharmacology
Study revealed, at clinical concentration, propofol will activate GABA A receptor directly or block sodium channel resulting glutamate release suppression. Glutamate excessive accumulation inside extracellular space caused by central nervous system (CNS) ischemia is believed as early cascade of permanent neuron damage. Massive glutamate release following ischemia will over-stimulate glutamate ionotropic and metabotropic receptor and cause neuron damage. (1,β) Propofol also suppress NMDA receptor and reduces calcium inlux through calcium channel. Calcium inlux into the cells will increase intracelluler calcium and activate some enzymes like protease, lipase and endonuclease. These enzymes will degrade the cell components. NMDA receptor
Mechanism of Action Clinical Effect
antagonist shows neuroprotective characteristic to focal and global cerebral ischemia. Studies show variation results, in some studies propofol increase NMDA receptor effect to intracellular calcium but on the contrary propofol reduces glutamate neurotoxic effect through NMDA receptor. There is a possibility propofol neuroprotective eficacy only last for short time. Based on those results, propofol seems only block NMDA receptor partially. (1,β) cautiously. Ephedrine, which has -adrenergic effect, is preferable because has positive inotropic and chronotropic effect. Ephedrine also releases nitric oxide (NO) into uterus circulation so Uterus Blood Flow (UBF) can be maintained. Phenylephrine, a selective α1-adrenergic receptor agonist, increase blood pressure through peripheral vasoconstriction so it used rarely because can interfere uterus circulation, especially in severe preeclampsia which is peripheral vasoconstriction occurred and phenylephrine can cause a high blood pressure spike.(1,β,γ)
Effect to Respiratory System
Propofol causes center respiratory and laryngeal relex suppression. The side effects to the respiratory system include decrease respiratory rate, bradipnea and even apnea. Bradipnea, both in human and animal, due to respiratory acidosis. Endotracheal intubation and mechanical ventilation can be done to prevent the complication if propofol used as anesthesia maintenance. (1,β) Hypothalamic-pituitary-adrenal axis (HPA) is a major endocrine stress axis in human. Cortisol ia a major stress hormone in this axis and inluences metabolism, cardiovascular and CNS either acute or chronic phase. During acute stress, cells in paraventricular nucleus (PVN) at hypothalamus will release Corticotropin Releasing Hormone (CRH), it stimulates the pituitary gland to release Adrenocorticotropic Hormone (ACTH) release into the blood stream. ACTH at the adrenal cortex will release the cortisol secretion into the blood. Generally all cells in human body have cortisol receptor so cortisol gives a wide range effect to all body systems including metabolism, cardiovascular and immune response. (4) Cortisol regulates it's release through negative feedback mechanism in CNS through speciic receptor binding in all limbic system, including hippocampus (HC), amygdala (AG) and prefrontal cortex (PFC). Cortisol basal secretion in no stress condition follows circadian rhythm, starts as spike elevation at morning followed by gradual decrease along the day and has a lowest level in the evening. Studies on propofol effect to stress response is very limited. One of the studies compares cortisol, adrenaline, noradrenaline, glucose and interleukin (IL)-6 level in female patients (aged 18-65 years old) with American Society of Anesthesiologists (ASA) I or II who were given propofol and sevolurane induction and underwent total hysterectomy. Propofol induction used Total Intra Venous Anesthesia (TIVA) and sevolurane used Volatile Inhalation Mask Anesthesia (VIMA). Propofol was given with early concentration 2.5 µg/ml with remifentanyl 5.0 ng/ml addition. Maintenance anesthesia achieved with propofol and remifentanyl dose adjustment. Sevolurane was given 6 vol%, N 2 O 6 L/minute and O 2 2 L/minute for 5 minutes with maintenance dose 1.5 vol%. The result showed cortisol, adrenaline, noradrenaline, and glucose have a signiicant lower level at induction (T1), intubation (Tβ), incision (Tγ) and extubation (T4) with propofol compare to sevolurane, but IL-6 level has no differences between the two groups. (7) Other study compared between propofol and sevolurane effect in animal gave the same result. Cortisol and noradrenaline level in propofol anesthesia were lower than sevolurane anesthesia after premedication (t0), immediately after surgery procedure inished (t1) and four hours after anesthesia inished (tβ).(6,7) Study compared propofol and isolurane effect to cortisol, glucose and C-Reactive Protein (CRP) in women aged 16-50 years old with ASA I or II classiication underwent gynecologic laparoscopic also showed cortisol and glucose level were lower signiicantly in propofol than isolurane but CRP level has no differences between two groups. Cortisol, glucose and CRP examination were done after intravenous access established (P0), 60 minutes after incision (P1) and 60 minutes after surgery (Pβ). (8) As a sedative agent, propofol is commonly administered for sedation in ICU patients to minimize the physiological responses to a variety of noxious stimuli including factors related to patient's condition, invasive procedures and to enhance patient tolerance to mechanical ventilation. Adequate sedation is known to reduce complications from stress response such as stimulation of the sympathetic nervous system, alteration of hormonal order and immunosuppression. Propofol has been associated with a reduction in blood cortisol levels, but responsiveness to a adrenocorticotropic hormone challenges was not changed. Propofol gains it's popularity because it has a rapid onset and offset compared with other commonly used ICU sedatives. (9) Besides the relation to stress response, the ICU stay may lead to psychological problems as well. Many patients developing post-traumatic stress syndromes have reported memories of vivid nightmares, hallucinations and altered sense of reality after their discharge from the ICU. Sedation also has been proposed as a neuroprotective strategy in head-injured patients and in status epilepticus. Propofol can achieve many of these goals, taking into consideration that this drug does not have analgesic properties and that it might be administered in combination with other classes of drugs to maximize beneits and minimize side effects relating to single drug use. (9) One study compared the sedative eficacy of propofol to midazolam at patients after Coronary Artery Bypass Graft (CABG) surgery and showed propofol has a shorter mean duration of sedative infusion in ICU, lower fentanyl as analgetic agent and shorter extubation time than patients sedated with midazolam. (10) Propofol Effect to Oxidative Stress Propofol is an lipophylic and phenolic antioxidant which can neutralize free radical, decrease lipid peroxidation, inhibit oxidative damage and increase glutathion level in tissue. Chemical structure of propofol has similarity with phenol based antioxidant like vitamin E. Studies showed propofol has antioxidant capacity similar with water soluble vitamin E analog (Trolox C). Propofol and vitamin E has equal abillity in increasing cell function at isolated cell membrane and the effect has a correlation with lipid peroxidation. With other word, propofol can replace vitamin E as an antioxidant. Another studies showed that propofol has a protective effect to oxidative stress so can stabilize mitochondria membrane. (1,β,11-14) Studies about the corelation between propofol with MDA in human, only calculate and compare MDA level in normal human, unpregnant woman, normal pregnancy and preeclampsia. Studies in speciic condition, like preeclampsia, were very limited. (14) (15) (16) (17) (18) Almost earlier studies about this issue were done in animal experiment. One of studies shows that anesthesia with propofol in animal provides a positive effect to oxidative status of erythrocyte through antioxidant enzyme activity attenuation like Sodium dismutase (SOD), Catalase (Cat) and Glutathione peroxidase (GPx). This study compared intravenous anesthesia with propofol and inhalation anesthesia with sevolurane. The result showed that animal with propofol anesthesia has higher antioxidant enzymes level than animal with isolurane anesthesia.(15) Other study described propofol will attenuate oxidative status through MDA level reduction during endotoxaemia. The study result showed an animal group with higher propofol concentration (γ0 mg/kg/hour) had a lower MDA level than groups with lower propofol concentration (15 mg/kg/hour). (17) Studies in human showed similar results. One study compared the effects of propofol and halothane anesthesia on oxidative stress by determining MDA levels during knee arthroplasty. In this study, a statistically signiicant MDA decrease only occurred in propofol anesthesia. (18) This in vivo results were further conirmed by two studies demonstrating propofol was more eficient than fentanyl in suppressing lipid peroxidation, F2-isoprostanes, complement C5a and neutrophil adhesion rate during coronary artery bypass grafting operations. The irst study showed propofol attenuates myocardial lipid peroxidation during coronary artery bypass grafting surgery. This study examined twenty four patients undergoing CABG surgery for triple vessel disease divided into two groups. After induction of anesthesia with fentanyl 10 µg/kg and midazolam 0.1 mg/kg, patients in the fentanyl group received fentanyl infusion 10-30 µg/kg/hour and patients in the propofol group received propofol infusion γ-6 mg/ kg/hour for anesthesia maintenance. The result showed TBARS level was less signiicantly in propofol group than fentanyl group. (19) The second study included thirty adult patients referred for elective cardiac procedure with Cardio Pulmonary Bypass (CPB) and randomly allocated to a propofol group or a control group. Patients in the propofol group received propofol 0.1 mg/kg/minute intravenously for anesthesia maintenance, whereas those in the control group received fentanyl 10 µg/kg intravenously and inhaled enlurane 1%-1.5%. The result showed there were signiicantly higher levels of F2-isoprostanes, C5a, and more neutrophils adhering to endothelial cells in the control group than those in the propofol group, respectively.(β0)
Immunomodulation Effect

Anxiolytic, Analgesic and Anticonvulsion Effects
Propofol has anxiolytic effect without sedation. Propofol anxiolytic mechanism probably involves a positive modulation of GABA inhibition function through GABA A receptor. This effect can be beneicial in anxious patients, as severe preeclampsia patient, who has a high anxiety level.
(1,β)
Analgesic effect of propofol gives variation results in studies. Some of studies showed propofol can modulate pain through opioid system with onset 5 to 20 minutes. Other studies showed propofol has no analgesic effect and maybe can cause a hyperalgesic effect. (1,β) Propofol anticonvulsion effect was found in two model studies using status epilecticus state in rabbit. In those studies, propofol with 12 mg/kg dose can suppress convulsion, and proved with EEG. In human, propofol known effective to prevent refractory status epilepticus to standard anticonvulsion. Anticonvulsion effect may be useful in convulsion prevention that occured frequently in severe preeclampsia. (1,β) 
Conclusion
Propofol has advantages as anti-stress response and antioxidant effect. Based on these beneits, propofol can be used as adjuvant therapy in conditions with a high stress response and oxidative stress such as surgery and during ICU stay.
